ImportantProduct launch
Aakaar Medical Technologies launches Letybo, a USFDA-approved botulinum toxin, for the Indian market.
Aakaar Medical Technologies LimitedAAKAAR · Filed with the exchange
This strategic move into the high-growth medical aesthetics segment boosts credibility and aims for deeper market penetration via flexible pricing.
No comments yet. Be the first.